ALLOS THERAPEUTICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9901578 Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancerJul 17, 13Feb 27, 18[A61K]
9187481 (2S)-2-[[4-[(1R)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amin]pentanedioic acid for the treatment of inflammatory disordersAug 25, 14Nov 17, 15[C07D]
8835433 Optically pure diastereomers of 10-Propargyl-10-deazaaminopterin and methods of using same for the treatment of cancerMar 13, 13Sep 16, 14[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0178,441 Methods for Extending Progression-Free Survival using 10-Propargyl-10-DeazaaminopterinAbandonedAug 05, 11Jul 11, 13[A61K]
2013/0143,891 Methods for Treating Methotrexate-Resistant Disorders with 10-Propargyl-10-DeazaaminopterinAbandonedJun 02, 11Jun 06, 13[A61K]
2011/0190,305 Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using SameAbandonedMar 04, 10Aug 04, 11[A61K, C07D, A61P]
2010/0248,249 Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr LevelsAbandonedMay 13, 10Sep 30, 10[C12Q]
2009/0048,262 COMBINATION OF 10-PROPARGYL-10-DEAZAAMINOPTERIN AND ERLOTINIB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCERAbandonedAug 18, 08Feb 19, 09[A61K]
2008/0039,425 Methods and Compositions to Reduce Tissue Irritation in Parenteral FormulationsAbandonedAug 02, 05Feb 14, 08[A61K]
2007/0293,698 Compositions of Allosteric Hemoglobin Modifiers and Methods of Making the SameAbandonedApr 22, 05Dec 20, 07[C07C, G01N]
2007/0259,966 Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of CancerAbandonedApr 22, 05Nov 08, 07[A61K, A61P]
2007/0212,302 Preparation and Use of a Stable Formulation of Allosteric Effector CompoundsAbandonedMay 16, 07Sep 13, 07[A61K, A61B]
7097825 Methods and reagents to acquire MRI signals and imagesExpiredFeb 25, 02Aug 29, 06[A61B]
2005/0238,727 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancerAbandonedApr 22, 05Oct 27, 05[A61K, A61N]
2005/0154,062 Substituted chiral allosteric hemoglobin modifiersAbandonedNov 17, 04Jul 14, 05[A61K, C07C]
2005/0148,991 Device for using patient blood as diluent in administering pharmaceuticalsAbandonedNov 16, 04Jul 07, 05[A61B, A61M]
6894185 Substituted chiral allosteric hemoglobin modifiersExpiredSep 10, 02May 17, 05[C07C]
2003/0232,887 Preparation and use of a stable formulation of allosteric effector compoundsAbandonedApr 10, 02Dec 18, 03[A61K]
6534501 Allosteric inhibitors of pyruvate kinaseExpiredMar 07, 01Mar 18, 03[A61K]
6486342 Substituted chiral allosteric hemoglobin modifiersExpiredAug 23, 00Nov 26, 02[C07C]
6214879 Allosteric inhibitors of pyruvate kinaseExpiredMar 24, 98Apr 10, 01[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.